BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1626959)

  • 1. Ultraviolet-B phototherapy for early-stage cutaneous T-cell lymphoma.
    Ramsay DL; Lish KM; Yalowitz CB; Soter NA
    Arch Dermatol; 1992 Jul; 128(7):931-3. PubMed ID: 1626959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides.
    Ponte P; Serrão V; Apetato M
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):716-21. PubMed ID: 19929938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extent of skin involvement as a prognostic indicator of disease free and overall survival of patients with T3 cutaneous T-cell lymphoma treated with total skin electron beam radiation therapy.
    Quiros PA; Kacinski BM; Wilson LD
    Cancer; 1996 May; 77(9):1912-7. PubMed ID: 8646693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma.
    Wilson LD; Quiros PA; Kolenik SA; Heald PW; Braverman IM; Edelson RL; Kacinski BM
    J Am Acad Dermatol; 1996 Jul; 35(1):69-73. PubMed ID: 8682967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
    Funk A; Hensley F; Krempien R; Neuhof D; Van Kampen M; Treiber M; Roeder F; Timke C; Herfarth K; Helmbold P; Debus J; Bischof M
    Eur J Dermatol; 2008; 18(3):308-12. PubMed ID: 18474461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
    Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
    J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of maintenance phototherapy in cutaneous T-cell lymphoma.
    Pothiawala SZ; Baldwin BT; Cherpelis BS; Glass LF; Fenske NA
    J Drugs Dermatol; 2010 Jul; 9(7):800-3. PubMed ID: 20677536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum soluble interleukin 2 receptor levels in erythrodermic cutaneous T-cell lymphoma correlate with response to photopheresis-based treatment.
    Goldman BD; Oh SK; Davis BE; Kadin ME; Poiesz BJ; Koh HK
    Arch Dermatol; 1993 Sep; 129(9):1166-70. PubMed ID: 8363402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of phototherapy in cutaneous T-cell lymphoma.
    Pothiawala SZ; Baldwin BT; Cherpelis BS; Lien MH; Fenske NA
    J Drugs Dermatol; 2010 Jul; 9(7):764-72. PubMed ID: 20677530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of early stages of mycosis fungoides with narrowband ultraviolet B. A clinical, histological and molecular evaluation of results.
    Dereure O; Picot E; Comte C; Bessis D; Guillot B
    Dermatology; 2009; 218(1):1-6. PubMed ID: 18832806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Narrow band UVB therapy in early stage mycosis fungoides. A study of 23 patients].
    Coronel-Pérez IM; Carrizosa-Esquivel AM; Camacho-Martínez F
    Actas Dermosifiliogr; 2007 May; 98(4):259-64. PubMed ID: 17506957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Total skin electron beam irradiation in cutaneous T-cell lymphoma].
    Rübe C; Busch M; Willich N; Hess F; Schönekäs K; Kaudewitz P; Wendt T; Feist H; Dühmke E
    Strahlenther Onkol; 1996 Feb; 172(2):74-80. PubMed ID: 8669048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.
    Querfeld C; Rosen ST; Kuzel TM; Kirby KA; Roenigk HH; Prinz BM; Guitart J
    Arch Dermatol; 2005 Mar; 141(3):305-11. PubMed ID: 15781671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of polymorphic variants in endothelin-1 (EDN1) genes with the therapy of patients with cutaneous T-cell lymphomas].
    Vasků V; Bienertová-Vasků J; Pávková-Goldbergová M; Semrádová V; Vasků A
    Cas Lek Cesk; 2006; 145(2):144-7. PubMed ID: 16521405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
    Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous lymphoma: local control and survival in patients treated with radiotherapy.
    De Sanctis V; Osti MF; Berardi F; Ardito F; Valeriani M; Martelli M; Enrici RM
    Anticancer Res; 2007; 27(1B):601-5. PubMed ID: 17348448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total skin electron beam therapy for cutaneous T-cell lymphoma: a nationwide cohort study from Denmark.
    Lindahl LM; Kamstrup MR; Petersen PM; Wirén J; Fenger-Grøn M; Gniadecki R; Iversen L; Specht L
    Acta Oncol; 2011 Nov; 50(8):1199-205. PubMed ID: 21736502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides.
    Boztepe G; Sahin S; Ayhan M; Erkin G; Kilemen F
    J Am Acad Dermatol; 2005 Aug; 53(2):242-6. PubMed ID: 16021117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management strategies for cutaneous T-cell lymphoma.
    Knobler E
    Clin Dermatol; 2004; 22(3):197-208. PubMed ID: 15262305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
    Ahmad K; Rogers S; McNicholas PD; Collins P
    Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.